• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
  • My 101
  • Research
  • Brief CV
  • Publications
  • Contact
  • Lab Staff
  • Lab Website
  • News
Home - Science - Scientist Directory - Guthridge, Joel

Joel Guthridge, Ph.D.

Associate Member
Arthritis & Clinical Immunology Research Program

My 101

My laboratory research focuses on understanding mechanisms that contribute to the development and progression of human autoimmune diseases. We expand upon more than 20 years of pioneering genetic work done at OMRF that defined what and which genes contribute to a patient’s risk to develop an autoimmune disease. Now we focus on understanding how those genes work, the mechanisms that are changed in one’s cells that lead eventually to autoimmunity.

It is imperative that we better understand the underlying causes and progression of systemic autoimmune diseases like lupus, multiple sclerosis and others, and that task requires unraveling vast networks of interconnected immune responses. Our primary focus is defining, at a systems level, the pathways that influence the regulation and development of autoimmune responses. Ultimately, this information can be used either to define pathways that contribute to disease characteristics in those patients, thereby identifying the drug targets for that subgroup of patients, or it can allow physicians to better predict the disease course of a patient, tailoring treatments to the individual’s unique profile.

All of our research revolves around interfacing with and pushing the limits of what we can do for the patients in OMRF’s clinics for lupus, multiple sclerosis, rheumatoid arthritis, Sjögren’s and other autoimmune conditions. Our ultimate goals are: 1) to improve patient care by helping create more accurate diagnostic tools and new methods to determine a person’s risk of developing a disease or predicting how individuals will respond to certain medications, and 2) to understand molecular pathways that contribute to the development or progression of the disease, and thereby identify potential new drug targets that will help treat these devastating diseases.

 

Research

My research focuses on understanding the etiology and pathogenesis of systemic autoimmune diseases. This requires unraveling vast networks of interconnected immune responses, a task that exceeds the limitations of traditional laboratory methods. My group applies high-throughput/high-content, precision medicine approaches to this problem. Our primary focus is defining, at a systems level, the pathways that influence the regulation and development of autoimmune responses.

I was involved in some of the early candidate gene association studies, and then in the whole genome association studies in lupus. I have also been intimately involved with large consortium studies and many follow-up fine mapping studies through my management of several large collections of lupus samples and data in the OMRF Biorepository and Sample Procurement Core. These results led to studies on the functional effects of disease-associated genetic variants, particularly in genes affecting the complement regulatory proteins/receptors, innate immune responses, and B cell signaling pathways.

To gain a high-level view of immune function in patients with autoimmune disease, we use a systems biology approach to combine data from our genetic/genomic studies, innovative biomarker assessments, cellular immunophenotyping experiments, and single cell proteomics analyses. Because multiple immune pathways can lead to the same autoimmune disease diagnosis, we also use these multidimensional datasets and associated clinical data to cluster patient subpopulations and model altered pathways in various populations. We apply these methods both in translational studies of cross-sectional and longitudinal autoimmune disease cohorts, and in investigator-initiated clinical trials. The ultimate goal of this work is to enable more accurate diagnosis, risk assessment before clinical disease onset, and prediction of therapeutic responses in order to improve patient care.

Brief CV

B.S., University of Iowa, Iowa City, IA, 1985
Ph.D., University of Kentucky, Lexington, KY, 1992
Postdoc, University of Colorado Health Sciences Center, Denver, CO, 1996
MSCIS, Regis University, Denver, CO

Joined OMRF scientific staff in 2002

Publications

View more publications

Recent Publications

Slief M, Kheir JM, Smith M, Mowery C, Macwana S, DeJager W, Wagner CA, Aberle T, Guthridge JM. Genetic load in incomplete lupus erythematosus. Lupus Sci Med 10, 2023 January, PMID: 36599633, PMCID: PMC9815005

Joachims ML, Khatri B, Li C, Tessneer KL, Ice JA, Stolarczyk AM, Means N, Grundahl KM, Glenn SB, Kelly JA, Lewis DM, Radfar L, Stone DU, Guthridge JM, James JA, Scofield RH, Wiley GB, Wren JD, Gaffney PM, Montgomery CG, Sivils KL, Rasmussen A, Farris AD, Adrianto I, Lessard CJ. Dysregulated long non-coding RNA in Sjögren's disease impacts both interferon and adaptive immune responses. RMD Open 8, 2022 November, PMID: 36456101, PMCID: PMC9717416

Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, Glenn SB, Hammenfors D, Imgenberg-Kreuz J, Jensen JL, Johnsen SJA, Jonsson MV, Kvarnström M, Kelly JA, Li H, Mandl T, Martín J, Nocturne G, Norheim KB, Palm Ø, Skarstein K, Stolarczyk AM, Taylor KE, Teruel M, Theander E, Venuturupalli S, Wallace DJ, Grundahl KM, Hefner KS, Radfar L, Lewis DM, Stone DU, Kaufman CE, Brennan MT, Guthridge JM, James JA, Scofield RH, Gaffney PM, Criswell LA, Jonsson R, Eriksson P, Bowman SJ, Omdal R, Rönnblom L, Warner B, Rischmueller M, Witte T, Farris AD, Mariette X, Alarcon-Riquelme ME, PRECISESADS Clinical Consortium., Shiboski CH, Sjögren’s International Collaborative Clinical Alliance (SICCA)., Wahren-Herlenius M, Ng WF, UK Primary Sjögren’s Syndrome Registry., Sivils KL, Adrianto I, Nordmark G, Lessard CJ. Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nat Commun 13:6519, 2022 October, PMID: 36316359, PMCID: PMC9622850

Selected Publications

Lu R, Munroe ME, Guthridge JM, Bean KM, Fife DA, Chen H, Slight-Webb SR, Keith MP, Harley JB, James JA. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun. Nov;74:182-193. PMID: 27338520 PMCID: PMC5079766

Slight-Webb S, Lu R, Ritterhouse LL, Munroe ME, Maecker HT, Fathman CG, Utz PJ, Merrill JT, Guthridge JM, James JA. 2016. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity. Arthritis Rheumatol. Oct;68(10):2492-502. PMID: 27059145 PMCID: PMC5042816

Dozmorov I, Dominguez N, Sestak AL, Robertson JM, Harley JB, James JA, Guthridge JM. 2013. Evidence of dynamically dysregulated gene expression pathways in hyperresponsive B cells from African American lupus patients. PLoS One. 8(8):e71397. PMID: 23977035 PMCID: PMC3744560

Guo L, Deshmukh H, Lu R, Vidal GS, Kelly JA… and Guthridge JM. 2009. Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population. Genes Immun 10(5):531-8. PMID: 19339986 PMCID: PMC2736873

The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN) , Harley JB, Alarcón-Riquelme ME, Criswell LA, Jacob CO… Guthridge JM, et al. 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies risk variants in ITGAM, PXK KIAA1542 and other loci. Nat Genet. 40(2):204-10. PMID: 18204446 PMCID: PMC3712260

Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P… Guthridge JM*, and Harley JB*. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet. 2008;40(2):152-4. (*authors contributed equally) PMID: 18204448

 

Contact

Arthritis & Clinical Immunology Research Program, MS 53
Oklahoma Medical Research Foundation
825 N.E. 13th Street
Oklahoma City, OK 73104

Phone: (405) 271-2600
Fax: (405) 271-7063
E-mail: Joel-Guthridge@omrf.org

For media inquiries, please contact OMRF’s Office of Public Affairs at news@omrf.org.

Lab Staff

Miles Smith, Ph.D.
Bioinformatics Scientist

Susan Macwana
Manager Core Facility

Marci Beel
Manager Laboratory

Matthew "Caleb" Marlin, Ph.D.
Project Manager

Jeanette Smith
Assistant Laboratory Manager

Wade DeJager
Senior Scientific Systems and Data Management Developer

Nicolas Dominguez
Senior Technical Specialist

Karla Kaminski
Clinical Data Systems Analyst

Laura Battiest
Research Technician III

Hunter Barnard
Research Technician

Toi Cook
Research Technician

Jelena "Jay" Grubisic
Research Technician

Kora Goddard
Research Technician

Benjamin "Ben" Jones
Research Technician

Tayte Stephens
Research Technician

Aleksandra Bylinska
Graduate Student

Glenda Kimes
Administrative Assistant III

News from the Guthridge lab

Dr. Guthridge in the Media

News from the Guthridge lab

Dr. Guthridge in the Media

Researchers gain better understanding of lupus
MuskogeePhoenix.com

Business people: OMRF announces promotions
Oklahoman.com

Lupus treatments can be tailored to patient's individual cells, study shows
CheckOrphan.org

Testing individual cells to guide treatment
BrightSurf.com

Lupus treatments can be tailored to patient's individual cells
MoneySavvyLiving.com

New OMRF findings pave way for better lupus treatments
EdmondSun.com

OMRF reports more effective lupus treatments
JournalRecord.com

Oklahoma business briefs: OMRF researchers win grants to study lupus
NewsOk.com

OMRF awarded grants to study lupus genes
JournalRecord.com

One of the coldest places in Oklahoma also holds precious medical science
KFOR.com

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace